AI-Powered HER2 IHC Expression Quantification
Research Use Only. Not for use in diagnostic procedures
Enhance Accuracy of
HER2 Scoring with AI
Analysis
Request More InfoBenefits
Reduce inter-observer
variation
Detect more HER2-low from
HER2-negative
Enhance pathologist
concordance and accuracy
Based on immunohistochemistry slide analysis,
Lunit SCOPE HER2 provides more accurate
scoring, including for HER2-low
Lunit SCOPE HER2 detected an additional 20%-33.5% of HER2-positive cases that were previously classified as HER2-negative across various tissue types
| Institution A | HER2-neg | HER2 1+ | HER2 2+ | HER2 3+ |
|---|---|---|---|---|
| AI HER2-neg | 125 (66.4%) | 59 | 3 | 1 |
| AI HER2 1+ | 8 | 96 (86.5%) | 7 | 0 |
| AI HER2 2+ | 0 | 11 | 21 (2.5%) | 8 |
| AI HER2 3+ | 0 | 0 | 4 | 218 (98.2%) |
| Institution B | HER2-neg | HER2 1+ | HER2 2+ | HER2 3+ |
|---|---|---|---|---|
| AI HER2-neg | 20 (80%) | 5 | 0 | 0 |
| AI HER2 1+ | 5 | 28 (80%) | 2 | 0 |
| AI HER2 2+ | 0 | 33 | 63 (65.6%) | 0 |
| AI HER2 3+ | 0 | 0 | 1 | 40 (75%) |